204 related articles for article (PubMed ID: 7710941)
21. Study of c-erbB-2 protein and epidermal growth factor receptor expression and DNA ploidy pattern in colorectal carcinoma.
Nakae S; Shimada E; Urakawa T
J Surg Oncol; 1993 Dec; 54(4):246-51. PubMed ID: 7902886
[TBL] [Abstract][Full Text] [Related]
22. Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.
Schimmelpenning H; Eriksson ET; Falkmer UG; Azavedo E; Svane G; Auer GU
Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):433-40. PubMed ID: 1350695
[TBL] [Abstract][Full Text] [Related]
23. Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations.
Fléjou JF; Paraf F; Muzeau F; Fékété F; Hénin D; Jothy S; Potet F
J Clin Pathol; 1994 Jan; 47(1):23-6. PubMed ID: 7907608
[TBL] [Abstract][Full Text] [Related]
24. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
[TBL] [Abstract][Full Text] [Related]
25. Oncogene expression in ovarian cancer: a pilot study of c-myc oncoprotein in serous papillary ovarian cancer.
Watson JV; Curling OM; Munn CF; Hudson CN
Gynecol Oncol; 1987 Oct; 28(2):137-50. PubMed ID: 3311922
[TBL] [Abstract][Full Text] [Related]
26. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
27. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.
Myers RB; Srivastava S; Oelschlager DK; Grizzle WE
J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137
[TBL] [Abstract][Full Text] [Related]
28. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract.
van Dam PA; Lowe DG; Watson JV; James M; Chard T; Hudson CN; Shepherd JH
Gynecol Oncol; 1991 Sep; 42(3):256-64. PubMed ID: 1683331
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
[TBL] [Abstract][Full Text] [Related]
30. The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer.
O'Reilly SM; Barnes DM; Camplejohn RS; Bartkova J; Gregory WM; Richards MA
Br J Cancer; 1991 Mar; 63(3):444-6. PubMed ID: 1672255
[TBL] [Abstract][Full Text] [Related]
31. Oestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.
Poller DN; Snead DR; Roberts EC; Galea M; Bell JA; Gilmour A; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1993 Jul; 68(1):156-61. PubMed ID: 8100443
[TBL] [Abstract][Full Text] [Related]
32. Ki 67 expression in 35 borderline ovarian tumours: relations with clinicopathologic parameters and ploidy.
Darai E; Walker-Combrouze F; Dauge-Geoffroy MC; Vincent Y; Feldmann G; Madelenat P; Scoazec JY
Eur J Obstet Gynecol Reprod Biol; 1998 Feb; 76(2):175-80. PubMed ID: 9481570
[TBL] [Abstract][Full Text] [Related]
33. Hormonal activity of epithelial ovarian tumours in post-menopausal women.
Heinonen PK; Mörsky P; Aine R; Koivula T; Pystynen P
Maturitas; 1988 Mar; 9(4):325-38. PubMed ID: 3380017
[TBL] [Abstract][Full Text] [Related]
34. Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer.
Lemoine NR; Jain S; Silvestre F; Lopes C; Hughes CM; McLelland E; Gullick WJ; Filipe MI
Br J Cancer; 1991 Jul; 64(1):79-83. PubMed ID: 1677259
[No Abstract] [Full Text] [Related]
35. P53 protein expression and DNA ploidy in common epithelial tumors of the ovary.
Ioakim-Liossi A; Karakitsos P; Aroni K; Delivelioti K; Fotiou V; Fotiou S; Kyrkou K
Acta Cytol; 1997; 41(6):1714-8. PubMed ID: 9390130
[TBL] [Abstract][Full Text] [Related]
36. A flow cytometric study of c-erbB-3 expression in breast cancer.
Brotherick I; Shenton BK; Angus B; Waite IS; Horne CH; Lennard TW
Cancer Immunol Immunother; 1995 Nov; 41(5):280-6. PubMed ID: 8536273
[TBL] [Abstract][Full Text] [Related]
37. The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer.
de Graeff P; Crijns AP; Ten Hoor KA; Klip HG; Hollema H; Oien K; Bartlett JM; Wisman GB; de Bock GH; de Vries EG; de Jong S; van der Zee AG
Br J Cancer; 2008 Jul; 99(2):341-9. PubMed ID: 18628764
[TBL] [Abstract][Full Text] [Related]
38. Expression of apoptosis-related proteins in endometriomas and benign and malignant ovarian tumours.
Fauvet R; Poncelet C; Hugol D; Lavaur A; Feldmann G; Daraï E
Virchows Arch; 2003 Jul; 443(1):38-43. PubMed ID: 12756564
[TBL] [Abstract][Full Text] [Related]
39. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
Prat J; Oliva E; Lerma E; Vaquero M; Matías-Guiu X
Cancer; 1994 Sep; 74(6):1778-83. PubMed ID: 7915964
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy analysis of borderline epithelial ovarian tumours.
Lodhi S; Najam S; Pervez S
J Pak Med Assoc; 2000 Oct; 50(10):349-51. PubMed ID: 11109755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
